This patent covers various hemaglobin beta chain derived sequences of peptides, as well as their use in combination with opioids for augmentation of hematopoiesis, as well as for antiviral and anticancer activities.
The products claimed by the patent appear easy to generate and are potentially useful for other regenerative applications besides stimulation of hematopoiesis.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.